Discussing Lupus: Belimumab in mucocutaneous lupus erythematosus and anifrolumab in SLE
Update: 2025-04-17
Description
Our Steering Committee experts Professor Victoria Werth and Chris Edwards join the latest Lupus Forum podcast to discuss the effect of belimumab vs placebo on mucocutaneous manifestations of SLE, and the long-term impact of anifrolumab vs placebo on LLDAS and DORIS attainment in patients with SLE. If you are interested in the papers discussed, head on over to the Lupus Forum today! Download our latest slide decks and stay up to date with our monthly podcasts, all through this free independent resource: https://lupus-forum.com/
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
